2018
Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial
Edelman EJ, Moore BA, Holt SR, Hansen N, Kyriakides TC, Virata M, Brown ST, Justice AC, Bryant KJ, Fiellin DA, Fiellin LE. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial. AIDS And Behavior 2018, 23: 211-221. PMID: 30073637, PMCID: PMC6476298, DOI: 10.1007/s10461-018-2241-z.Peer-Reviewed Original ResearchConceptsHIV-positive patientsHeavy drinking daysVACS Index scoreXR-NTXART adherenceDrinking daysIndex scoreUndetectable HIV viral loadCD4 cell countExtended-release naltrexoneDouble-blind placeboHIV viral loadRandomized-controlled trialDrinking outcomesHIV biomarkersSecondary outcomesHIV outcomesPrimary outcomeViral loadAntiretroviral adherenceClinical trialsCell countAlcohol treatmentHIVPatients
1998
Community Reinforcement Approach in the Treatment of Opiate Addicts
Abbott P, Weller S, Delaney H, Moore B. Community Reinforcement Approach in the Treatment of Opiate Addicts. The American Journal Of Drug And Alcohol Abuse 1998, 24: 17-30. PMID: 9513627, DOI: 10.3109/00952999809001696.Peer-Reviewed Original ResearchConceptsCommunity Reinforcement ApproachMethadone maintenanceCRA groupASI drug composite scoresSeverity Index scoreTreatment of patientsOpiate-dependent patientsAddiction Severity Index (ASI) scoresDrug composite scoresStandard counselingTreatment exposureReinforcement approachIndex scoreRelapse preventionStandard groupDrug screensOpiate addictsRP sessionsComposite scorePatientsAdditive effectIntakeMonthsTreatmentScores